A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Anastrozole|DRUG: AZD0530 (saracatinib)|DRUG: Placebo
Sponsor: Joyce Marie Slingerland
Collaborators: Stanford University